Brief: Biora Therapeutics Inc - Company Did Not Regain Compliance With Nasdaq's Mvls Rule By June 10, 2024
14/06/2024 22:47
Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS INC - COMPANY DID NOT REGAIN COMPLIANCE
WITH
NASDAQ'S MVLS RULE BY JUNE 10, 2024
* BIORA THERAPEUTICS:STAFF NOTIFIED CO THAT ITS SECURITIES
WERE
SUBJECT TO DELISTING FROM NASDAQ UNLESS COMPANY TIMELY REQUESTS
HEARING BEFORE PANEL
Source text for Eikon: ID:n0001193125-24-161664
Further company coverage: BIOR.O
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules